December 7, 2026-December 8, 2026 NIH/NCATS, C-Path Joint Meeting Please join us at the 28th NIH Tissue Chip Consortium Joint Meeting with the CC-Path's Complex In Vitro Model Qualification...
November 3, 2026 White House Signs off on ACT for ALS Reauthorization President Trump's signature provides final step to extending programs established by the original ACT for ALS through 2031.
October 30, 2026 Tau positron emission tomography harmonization using the CenTauR approach: General conversion equations, relevant cut-points, and external validation Tau positron emission tomography (PET) tracers differ in kinetics, binding properties...
October 29, 2026 Overcoming the challenges of rare disease clinical research Development of drugs to treat rare diseases faces unique challenges. Traditional placebo-controlled clinical trials may be difficu
October 9, 2026 Critical Path Institute Newsletter Q3 2026: Patient-Focused. Future-Ready. Evidence-Driven As we enter the final quarter of 2026, I continue to be inspired by the progress our community is making together. The past severa
October 2, 2026 C-Path Partners with University of Arizona on Translational Research of Parkinson’s Disease in Women TUCSON, Ariz., October 6, 2026 — Critical Path Institute® (C-Path) today announced a research collaboration with the University
October 1, 2026 Federal Investment Launches National Facility Dedicated to Advancing Non-Animal Drug Development Tools BALTIMORE; TUCSON, Ariz.; and WASHINGTON, Oct. 1, 2026 — The National Center to Accelerate Cures (NCAC)...
October 1, 2026 GATC Health Joins C-Path’s New Approach Methodologies Developer Coalition TUCSON, Ariz., October 1, 2026 — Critical Path Institute's® (C-Path) New Approach Methodologies Developer Coalition...
October 1, 2026 How NAMs are Redefining Drug Development The newest episode of the Critical Path Institute Podcast features C-Path CEO and host Klaus Romero...
September 28, 2026 Advancing Hope in Limb Girdle Muscular Dystrophies: Collaboration, Data, and Innovation During LGMDs Awareness Month Each September, Limb Girdle Muscular Dystrophies (LGMDs) Awareness Month shines a light on a devastating neuromuscular disease tha
